Axsome Therapeutics, Inc. (AXSM) EPS Estimated At $-0.33; Ellsworth Fund LTD (ECF) Sentiment Is 1.3 Standard RecorderAnalysts expect Axsome Therapeutics, Inc. (NASDAQ:AXSM) to report $-0.33 EPS on March, 6.They anticipate $0.05 EPS change or 17.86% from last quarter's ...